Inductionless or Limited Shock Testing Is Possible in Most Patients With Implantable Cardioverter- Defibrillators/Cardiac Resynchronization Therapy Defibrillators Results of the Multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations)

University of California, Davis, Davis, California, United States
Circulation (Impact Factor: 14.43). 06/2007; 115(18):2382-9. DOI: 10.1161/CIRCULATIONAHA.106.663112
Source: PubMed


Implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators have relied on multiple ventricular fibrillation (VF) induction/defibrillation tests at implantation to ensure that the device can reliably sense, detect, and convert VF. The ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations) is the first large, multicenter, prospective trial comparing vulnerability safety margin testing versus defibrillation safety margin testing with a single VF induction/defibrillation.
A total of 426 patients receiving an implantable cardioverter-defibrillator or cardiac resynchronization therapy defibrillator underwent vulnerability safety margin or defibrillation safety margin screening at 14 J in a randomized order. After this, patients underwent confirmatory testing, which required 2 VF conversions without failure at < or = 21 J. Patients who passed their first 14-J and confirmatory tests, irrespective of the results of their second 14-J test, had their devices programmed to a 21-J shock for ventricular tachycardia (VT) or VF > or = 200 bpm and were followed up for 1 year. Of 420 patients who underwent 14-J vulnerability safety margin screening, 322 (76.7%) passed. Of these, 317 (98.4%) also passed 21-J confirmatory tests. Of 416 patients who underwent 14-J defibrillation safety margin screening, 343 (82.5%) passed, and 338 (98.5%) also passed 21-J confirmatory tests. Most clinical VT/VF episodes (32 of 37, or 86%) were terminated by the first shock, with no difference in first shock success. In all observed cases in which the first shock was unsuccessful, subsequent shocks terminated VT/VF without complication.
Although spontaneous episodes of fast VT/VF were limited, there was no difference in the odds of first shock efficacy between groups. Screening with vulnerability safety margin or defibrillation safety margin may allow for inductionless or limited shock testing in most patients.

Download full-text


Available from: Jonathan Peter Weiss, Aug 29, 2014
  • Source
    • "The aim of a safety margin of 10 J – as in our study – lowers the probability of retesting. In addition, testing a 10 J safety margin tends to have enough evidence and is generally accepted [13]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Implantation of implantable cardioverter-defibrillators (ICD) from the left pectoral region is the standard therapeutical method. Increasing numbers of system revisions due to lead dysfunction and infections will consecutively increase the numbers of right-sided implantations. The reliability of devices implanted on the right pectoral side remains controversially discussed, and the question of testing these devices remains unanswered. Methods In a prospectively designed study all 870 patients (60.0±14 years, 689 male) who were treated with a first ICD from July 2005 until May 2012 and tested intraoperatively according to the testing protocol were analyzed. The indication for implantation was primary prophylactic in 71.5%. Underlying diseases included ischemic cardiomyopathy (50%), dilative cardiomyopathy (37%), and others (13%). Mean ejection faction was 27±12%. Implantation site was right in 4.5% and left in 95.5%. Results Five patients supplied with right-sided ICD (13%, p = 0.02 as compared to left-sided) failed initial intraoperative testing with 21 J. 3 patients were male. The age of the patients failing intraoperative testing with right-sided devices appeared higher than of patients with left-sided devices (p = 0.07). The ejection fraction was 28±8%. All patients reached a sufficient DFT ≤ 21 J after corrective procedures. Conclusion Implantation of ICDs on the right side results in significantly higher failure rate of successful termination of intraoperatively induced ventricular fibrillation. The data of our study suggest the necessity of intraoperative ICD testing in right-sided implanted ICDs.
    Full-text · Article · Apr 2013 · Journal of Cardiothoracic Surgery
  • [Show abstract] [Hide abstract]
    ABSTRACT: The performance of turbo TCH codes is analyzed in a (code spreading) CS-CDMA scheme, for spread spectrum applications in a multiuser and fast fading channel environment, with and without multipath. Several rates are considered, bearing in mind different types of service. In order to get an estimate of performance gains over an existing (direct sequence) DS-CDMA system, UMTS coding results are used for comparison against punctured turbo TCH codes, in order to compare equal coding rates. A simulator with the main code structure for both schemes was built, alongside the channel model and RAKE receiver, in order to correctly compare both coding schemes. Specific test conditions are defined, and the overall codes of both schemes are compared.
    No preview · Conference Paper · Jan 2004
  • [Show abstract] [Hide abstract]
    ABSTRACT: An optimal pilot embedding scheme is proposed for multipath channel identification. The scheme adds the columns of a Hadamard matrix to the transmitted signal to help estimate the channel. At the receiver, the channel is estimated as a function of the mean of the received blocks. A power allocation scheme is derived for approximately determining the optimal amount of power to allocate to the information symbols and the added pilot symbols.
    No preview · Conference Paper · Jan 2004
Show more